DNA Replication Initiator Proteins and Genetic Instability: Creating a Mouse Model for Prostate Cancer

Abstract

Hyperploidy is a well-known pathological hallmark of cancer cells including prostate cancer. The mechanisms underlying this form of genomic instability are essentially unknown. We have identified a pathway in fission yeast critical for maintaining DNA replication control. Two genes in the pathway, POPl and POP2, encode WD4C domain proteins that heterodimerize to hind to regulatory proteins and promote their ubiquitin-dependent proteolysis. The targets of this proteolytic destruction machinery include regulators of cyclin-dependent kinases, cyclins, Cdk inhibitors, and the replication initiator protein, Cdcl8. Mutations in Popl or Pop2 cause yeast to accumulate these regulators and to prominently overreplicate their genomes (>8N) . Accordingly, the POP genes behave as "rereplication suppressors" in yeast. We have identified human and mouse homologs of the POP genes which we have called hPOPl and mPOPl. These genes encode proteins that are overall 21% identical and 55% similar to yeast equivalents, hut have higher degrees of homology in some domains. We have begun to test whether these proteins serve a similar role in mammalian cells. Using radiation hybrid mapping and FISH, we have mapped the human POPl to a region that has been suggested to contain a potential tumor suppressor for urogenital cancer.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2000
Accession Number
ADA391522

Entities

People

  • Peter K Jackson

Organizations

  • Stanford University

Tags

DTIC Thesaurus Topics

  • Biomedical And Dental Materials
  • Cell Line
  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Chromosomes
  • Cytoskeleton
  • Fungi
  • Genetics
  • Medical Personnel
  • Polymer Chemistry
  • Polymeric Films
  • Proteins
  • Proteomics

Fields of Study

  • Biology

Readers

  • Molecular Biology and Genetics
  • Molecular Genetics
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology